Magnesium Sulfate Injection Market

This product is a colorless transparent liquid and can be used as an anticonvulsant. Lowering blood pressure and treating pre-eclampsia and eclampsia are also used to treat preterm labor.

Magnesium Sulfate Injection Market contains market size and forecasts of Magnesium Sulfate Injection in global, including the following market information:

Global Magnesium Sulfate Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Magnesium Sulfate Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Magnesium Sulfate Injection companies in 2021 (%)

The global Magnesium Sulfate Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Magnesium Sulfate Injection include Pfizer, Fresenius Kabi, American Regent, X-Gen, Exela, WG Critical Care, AdvaCare Pharma, Shanghai Xudong Help and Chengdu Brilliant Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Magnesium Sulfate Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Magnesium Sulfate Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnesium Sulfate Injection Market Segment Percentages, by Type, 2021 (%)

• 10mg/ml
• 40mg/ml
• 250mg/ml
• 500mg/ml
• Others

Global Magnesium Sulfate Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnesium Sulfate Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Magnesium Sulfate Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Magnesium Sulfate Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Magnesium Sulfate Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Magnesium Sulfate Injection revenues share in global market, 2021 (%)
• Key companies Magnesium Sulfate Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Magnesium Sulfate Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Fresenius Kabi
• American Regent
• X-Gen
• Exela
• WG Critical Care
• AdvaCare Pharma
• Shanghai Xudong Help
• Chengdu Brilliant Pharmaceutical
• Beijing Yimin Pharmaceutical
• Wuhan Jiuan Pharmaceutical
• Hebei Tiancheng Pharmaceutical
• Sinopharm Group
• Jinling Pharmaceutical
• Jiangsu Huayang Pharmacy
• Hangzhou Minsheng Pharmaceutical Industry Group